Company intelligence / Profile preview

Cheetah Medical

Boston, Massachusetts, United Statesusstarling.baxter.com ↗

Ownership: Private
Employees: ~100
Development stage: Commercial

Overview

Cheetah Medical’s noninvasive hemodynamic monitoring systems, including the Starling™ SV and NICOM platforms, are commercially available in over 30 countries. These devices provide real-time dynamic assessments of fluid responsiveness and cardiac output to guide optimal fluid therapy in critical care, perioperative, and emergency settings. Clinical studies have shown that their use can reduce ICU stays and healthcare costs by improving patient outcomes through personalized fluid management.

Therapeutic areas: OtherNephrologyInfectious Diseases
Modalities: Device (Noninvasive hemodynamic monitoring system)
Industry: Physiological Monitoring

Partnerships

Medtronic OEM partnershipSunTech MedicalIDS Medical Systems

Beyond the preview

Go deeper on Cheetah Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cheetah Medical.

Explore the full profile